Pharma companies set for strong performance in March 2025 quarter amid earning (...)
Sun Pharma is expected to post a 9% year-on-year revenue growth, supported by its US specialty portfolio and steady growth in chronic therapies in India.
Site référencé: The Economic Times
The Economic Times
Is the white metal ready for a catch-up rally ?
29/04/2025
RIL logs highest one-day gain in 11 months, could rise 11-22% more
29/04/2025
IndusInd Deputy CEO Khurana quits over accounting lapses
28/04/2025
Sebi comes out with timelines for brokers to collect margins
28/04/2025
CSB Bank Q4 Results : Net profit rises 26% to Rs 190 crore ; margins shrink
28/04/2025
NFO Alert : DSP Mutual Fund launches Silver ETF Fund of Fund
28/04/2025
